Andreas Scherer
andreasscherer.bsky.social
Andreas Scherer
@andreasscherer.bsky.social
At Golden Helix, I drive innovation in bioinformatics and clinical genomics. Passionate about bridging research and real-world outcomes with data-driven solutions. At Salto Partners, advising on growth and leadership in tech and life sciences.
We have just wrapped up a dynamic 2024. Please read my blog for more details on our strategy for the new year.

Here’s to an outstanding 2025!

#GoldenHelix #ClinicalGenomics #PrecisionMedicine #Cancer #Pharmacogenomics #BYOC #NGS #ISO13485 #CEMark

www.goldenhelix.com/blog/golden-...
Golden Helix: Charting Our 2025 Strategy
We just wrapped up a dynamic and rewarding 2024. Hence, we want to take a moment to celebrate key milestones that have set the stage for our next chapter. This year, we pushed our solutions to new fro...
www.goldenhelix.com
January 3, 2025 at 10:49 AM
Announcing CancerKB 4.0
✅ NCCN & FDA-approved therapies for blood cancers.
✅ Harmonized diagnostic & prognostic interpretations
✅ Expanded content: added 150 biomarkers, over 1,000 curated genes, and 65,000 clinical trials.
#CancerGenomics #CancerKB

www.goldenhelix.com/resources/we...
The Latest and Greatest Golden Helix CancerKB 4.0 and Somatic Analysis within VSClinical
Discover how Golden Helix CancerKB 4.0 and VSClinical streamline the analysis of somatic mutations, integrating the latest NCCN and WHO updates for hematological cancers.
www.goldenhelix.com
December 24, 2024 at 6:23 PM
We entered into a multi-year collaboration with the Bumrungrad International Hospital in Thailand. Together, we aim to support their genomics initiatives.

#GoldenHelix #Bumrungrad #rarediseases #cancer #pharmacogenomics

finance.yahoo.com/news/bumrung...
December 24, 2024 at 6:18 PM